In-Vitro Colorectal Cancer Screening Tests Market Size, Share, Growth Analysis, By Product Type(Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests, Guaiac FOB Stool Test), By End User(Hospitals, Clinics, Diagnostics laboratories, Ambulatory Surgical Centers), By Region - Industry Forecast 2024-2031

The North American, European, Asian-Pacific, Latin American, and Middle Eastern regions of the market for in-vitro colorectal cancer screening tests were used to split the market for regional analysis. In-vitro testing for colorectal cancer were the market leader in 2021 in North America.

Due to factors like an increasing geriatric population, rising cancer rates, high healthcare spending in the nation, and the presence of a sophisticated healthcare infrastructure, the United States currently holds the largest market share. These factors are expected to spur the growth of the in-vitro colorectal cancer screening tests market in this region.

However, due to the rising incidence of cancer in this region, Asia-Pacific is anticipated to have significant increase throughout the forecast period. Due to the growing elderly population in Asia and changes in lifestyle, cancer is becoming a bigger issue. For both men and women, in-vitro colorectal cancer is the third most deadly disease. Over the previous ten years, colorectal cancer mortality rates have increased in this area. By 2028, the market for in vitro tests for colorectal cancer screening in China would be worth over USD 90 million. The country's significant co-morbidities and risk factors, as well as the expanding colorectal cancer prevalence, are the main causes of this rapid industry growth. Except for Japan, Korea, Singapore, and Taiwan, there are no national recommendations for colorectal cancer screening in the majority of Asian nations.